Yonghe Medical (02279) Schedules 31 Mar 2026 Board Meeting to Review FY 2025 Results and Dividend Proposal

Bulletin Express
Mar 19

Yonghe Medical Group Co., Ltd. (02279) has announced that its Board of Directors will convene on 31 March 2026.

The meeting will focus on:

1. Reviewing and approving the consolidated financial results for the fiscal year ended 31 December 2025.

2. Considering the recommendation of a final dividend for the period, subject to Board approval.

3. Addressing any additional corporate matters raised during the session.

Board composition at the time of the announcement comprises three executive directors—ZHANG Yu, ZHANG Hui and HAN Zhimei; one non-executive director—GENG Jiaqi; and three independent non-executive directors—LIANG Jihong, CHAN Peng Kuan and LI Xiaopei.

The notice was signed by Chairman ZHANG Yu and dated 19 March 2026 in Hong Kong.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10